Synthesis and biological evaluation of novel phenothiazine derivatives as non-peptide arginine vasopressin V2 receptor antagonists

被引:0
|
作者
Shuang Zhi [1 ]
Shuai Mu [1 ,2 ]
Ying Liu [2 ]
Min Gong [2 ]
Ping-Bao Wang [2 ]
Deng-Ke Liu [2 ]
机构
[1] School of Chemical Engineering and Technology,Tianjin University
[2] Tianjin Institute of Pharmaceutical Research
关键词
Arginine vasopressin V2 receptor; antagonist; Phenothiazine derivatives; Synthesis; Biological activities;
D O I
暂无
中图分类号
O626 [杂环化合物];
学科分类号
摘要
A series of novel phenothiazine derivatives was synthesized and tested for arginine vasopressin receptor antagonist activity.They were synthesized as novel arginine vasopressin receptor antagonists from phenothiazine as a scaffold via successive acylation,reduction and acylation reactions.Their structures were characterized by ~1H NMR,C NMR and HRMS,and biological activity was evaluated by in vitro and in vivo studies.The in vitro binding assay indicated that several compounds are potent selective V2 receptor antagonists.Compounds with promising binding affinity to V2 receptors were selected to conduct the in vivo diuretic studies on Sprague-Dawley rats.Among them.In,1r,1t and 1v exhibited excellent diuretic activity,especially 1 rand 1 v.Therefore,1r and 1v are potent novel AVPV2 receptor antagonist candidates.
引用
收藏
页码:627 / 630
页数:4
相关论文
共 50 条
  • [41] Novel non-peptide lead structures for Bradykinin B2-receptor antagonists
    Pineda L.F.
    Liebmann C.
    Hensellek S.
    Paegelow I.
    Steinmetzer T.
    Schweinitz A.
    Stürzebecher J.
    Reissmann S.
    Letters in Peptide Science, 2000, 7 (2): : 69 - 77
  • [42] Benzodiazepine Derivatives as Potent Vasopressin V2 Receptor Antagonists for the Treatment of Autosomal Dominant Kidney Disease
    Cao, Xudong
    Wang, Peng
    Yuan, Haoxing
    Zhang, Haoran
    He, Yan
    Fu, Kequan
    Fang, Qian
    Liu, Hongli
    Su, Limin
    Yin, Long
    Xu, Pei
    Xie, Yuyang
    Xiong, Xiaochun
    Wang, Junqi
    Zhu, Xu
    Guo, Dong
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, : 9295 - 9311
  • [43] Novel non-peptide lead structures for Bradykinin B2-receptor antagonists
    Pineda, LF
    Liebmann, C
    Hensellek, S
    Paegelow, I
    Steinmetzer, T
    Schweinitz, A
    Stürzebecher, J
    Reissmann, S
    LETTERS IN PEPTIDE SCIENCE, 2000, 7 (02): : 69 - 77
  • [44] Structurally novel V2-selective and dual V1A/V2 vasopressin receptor antagonists.
    Dyatkin, AB
    Maryanoff, BE
    Hoekstra, WJ
    Hlasta, DJ
    Andrade-Gordon, P
    DeGaravilla, L
    Demarest, K
    Gunnet, J
    Look, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : A93 - A93
  • [45] Targeting GRP receptor: Design, synthesis and preliminary biological characterization of new non-peptide antagonists of bombesin
    Palmioli, Alessandro
    Nicolini, Gabriella
    Tripodi, Farida
    Orsato, Alexandre
    Ceresa, Cecilia
    Donzelli, Elisabetta
    Arici, Martina
    Coccetti, Paola
    Rocchetti, Marcella
    La Ferla, Barbara
    Airoldi, Cristina
    BIOORGANIC CHEMISTRY, 2021, 109
  • [46] Synthesis, binding studies, and in vivo biological evaluation of novel non-peptide antihypertensive analogues
    Mavromoustakos, T.
    Moutevelis-Minakakis, P.
    Kokotos, C. G.
    Kontogianni, P.
    Politi, A.
    Zoumpoulakis, P.
    Findlay, J.
    Cox, A.
    Balmforth, A.
    Zoga, A.
    Iliodromitis, E.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (13) : 4353 - 4360
  • [47] A NOVEL INTRAGENIC DELETION RELATED TO THE ARGININE VASOPRESSIN V2 RECEPTOR CAUSES NEPHROGENIC DIABETES INSIPIDUS
    Chen, L.
    Gu, T.
    Yang, L. Z.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2020, 16 (03) : 295 - 297
  • [48] Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?
    Hiroshi Fukui
    World Journal of Gastroenterology, 2015, (41) : 11584 - 11596
  • [49] Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?
    Fukui, Hiroshi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (41) : 11584 - 11596
  • [50] Design, synthesis and biological evaluation of novel biphenylsulfonamide derivatives as selective AT2 receptor antagonists
    Wang, Danhui
    Zhao, Wenjie
    Zhang, Zuzhi
    Zhang, Yanchun
    Li, Jiaming
    Huang, Weijun
    FRONTIERS IN CHEMISTRY, 2022, 10